Resultats de la cerca - Yukimasa Shiotsu
- Mostrar 1 - 7 resultats de 7
-
1
New Molecular and Biological Mechanism of Antitumor Activities of KW-2478, a Novel Nonansamycin Heat Shock Protein 90 Inhibitor, in Multiple Myeloma Cells per Takayuki Nakashima, Toshihiko Ishii, Hisashi Tagaya, Toshihiro Seike, Hiroshi Nakagawa, Yutaka Kanda, Shiro Akinaga, Shiro Soga, Yukimasa Shiotsu
Publicat 2010Artigo -
2
Systemic Distribution of Steroid Sulfatase and Estrogen Sulfotransferase in Human Adult and Fetal Tissues per Yasuhiro Miki, Taisuke Nakata, Takashi Suzuki, Andrew D. Darnel, Takuya Moriya, Chika Kaneko, Kumiko Hidaka, Yukimasa Shiotsu, Hideaki Kusaka, Hironobu Sasano
Publicat 2002Artigo -
3
A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients per Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi
Publicat 2007Artigo -
4
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response per Keith W. Pratz, Jorge E. Cortés, Gail J. Roboz, Niranjan Rao, Omotayo Arowojolu, Adam Stine, Yukimasa Shiotsu, Aiko Shudo, Shiro Akinaga, Donald Small, Judith E. Karp, Mark J. Levis
Publicat 2008Artigo -
5
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells per Naoko Wada, Yawara Kawano, Shiho Fujiwara, Yoshitaka Kikukawa, Yutaka Okuno, Masayoshi Tasaki, Mitsuharu Ueda, Yukio Ando, Kazuya Yoshinaga, Masaki Ri, Shinsuke Iida, Takayuki Nakashima, Yukimasa Shiotsu, Hiroaki Mitsuya, Hiroyuki Hata
Publicat 2014Artigo -
6
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation per Yukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, Ryohei Tanizaki, Makiko Shimizu, Hiroshi Umehara, Kenichi Ishii, Yumiko Mori, Kazutaka Ozeki, Yosuke Minami, Akihiro Abe, Hiroshi Maéda, Tadakazu Akiyama, Yutaka Kanda, Yuko Sato, Shiro Akinaga, Tomoki Naoe
Publicat 2009Artigo -
7
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing per Masaki Ri, Etsu Tashiro, Daisuke Oikawa, Satoko Shinjo, Mio Tokuda, Yumi Yokouchi, Takuma Narita, Masaki Arioka, Asahi Ito, Jian Ding, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Yukimasa Shiotsu, Ryuzo Ueda, Takao Iwawaki, Masaya Imoto, Shinsuke Iida
Publicat 2012Artigo
Eines de cerca:
Matèries relacionades
Biology
Biochemistry
Cancer research
Cell biology
Immunology
Medicine
Gene
Internal medicine
Molecular biology
Apoptosis
Biotechnology
Bortezomib
Cell cycle
Chemistry
Genetics
In vitro
In vivo
Kinase
Multiple myeloma
Myeloid leukemia
ABL
ATF6
Antibody
Antibody-dependent cell-mediated cytotoxicity
Autophosphorylation
Breast cancer
Cancer
Cell culture
Chromosomal translocation
Clinical trial